alternatives to glp-1 agonists How Receptor Evolved from Diabetes Weight Loss Treatments | https://lnkd.in/gH3rfnVe Thursday, March 14, 2024 8am PST // 11am EST // 4pm GMT Peptidic GLP-1R agonists have received… GLP-1 Drug Savings: A Complete

For instance, the SRD5A2 variant ( rs523349 ) significantly impacts the metabolism of DHT, affecting the efficacy of 5-alpha-reductase inhibitors like finasteride and dutasteride

Trials still pending Two core obesity trials are still running: TRIUMPH-2 (obesity + type 2 diabetes) results expected later 2026 TRIUMPH-3 (obesity + established cardiovascular disease) results expected later 2026 A separate cardiovascular outcomes trial, TRIUMPH-Outcomes (~10,000 patients), is not required for the initial obesity NDA and wont report until 20282029

Rheum Dis Clin North Am

doi: 10.1038/s41586-020-2918-0 206 ObayanA

Shah et al., 2008)

IV glutathione is favoured for skin brightening protocols, liver therapy, neurological support, and intensive detoxification programmes